[{"NetIncomeLoss_1_Q1_USD":-26795000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":107000.0,"ShareBasedCompensation_1_Q1_USD":2292000.0,"Assets_0_Q1_USD":187402000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":150866000.0,"StockIssuedDuringPeriodValueIssuedForServices_1_Q1_USD":129000.0,"CommonStockSharesIssued_0_Q1_shares":90169616.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q1_USD":-1000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":11216000.0,"AssetsCurrent_0_Q1_USD":187276000.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q1_USD":6976000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":13000.0,"InterestIncomeExpenseNonoperatingNet_1_Q1_USD":77000.0,"Depreciation_1_Q1_USD":13000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-7710000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":2000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":93311000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":8322000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_1_Q1_USD":19000000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":-1000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":0.0,"NumberOfReportableSegments_1_Q1_segment":1.0,"CommonStockValue_0_Q1_USD":90000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":-5816000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":129000.0,"OtherAssetsNoncurrent_0_Q1_USD":2000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":29335000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":51000.0,"Cash_0_Q1_USD":3300000.0,"Liabilities_0_Q1_USD":20214000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-26796000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":516000.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q1_USD":0.0,"CommonStockSharesOutstanding_0_Q1_shares":90169616.0,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":26710000.0,"IncreaseDecreaseInAccruedInterestReceivableNet_1_Q1_USD":-122000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-26795000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":2292000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-29457000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-37038000.0,"LiabilitiesCurrent_0_Q1_USD":20163000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":5310000.0,"AdditionalPaidInCapital_0_Q1_USD":758964000.0,"CashEquivalentsAtCarryingValue_0_Q1_USD":26000000.0,"NumberOfOperatingSegments_1_Q1_segment":1.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":17000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":29335000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":18549000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-591868000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":150864000.0,"CommonStockSharesAuthorized_0_Q1_shares":200000000.0,"OperatingIncomeLoss_1_Q1_USD":-26871000.0,"IncomeTaxesReceivable_0_Q1_USD":1765000.0,"IncreaseDecreaseInIncomeTaxesReceivable_1_Q1_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q1_pure":0.0,"AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":15000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":-395000.0,"PreferredStockValue_0_Q1_USD":0.0,"PreferredStockSharesAuthorized_0_Q1_shares":5000000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":2292000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":55000.0,"OperatingExpenses_1_Q1_USD":26871000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.29,"StockholdersEquity_0_Q1_USD":167188000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":187402000.0,"ClassOfWarrantOrRightOutstanding_0_Q1_shares":3164280.0,"Ticker":"ISEE","CIK":"1410939","name":"IVERIC BIO, INC.","OfficialName":"IVERIC bio Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1851737728.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210505"}]